Researchers at the University of Copenhagen have identified a new drug target for weight loss that curbs appetite, boosts ...

The new rules, which cover both TV and radio, instruct drugmakers to use simple, consumer-friendly language when describing ...

The Globe and Mail spoke with eight people whose pet’s health declined after taking Librela. Drugmaker Zoetis has responded ...

Novo Nordisk and Eli Lilly are facing scores of personal injury claims for allegedly failing to warn patients about side ...

Neurogene stock collapsed, again, on Monday after the company scrapped the high dose of its experimental Rett syndrome ...

Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage ...

Supreme Court dismisses plea mandating doctors to specify drug side effects, citing impracticality and existing regulations.

Researchers believe discovery will springboard research to make more tolerable, effective weight loss treatments accessible ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...